Fresenius Targets Nostrum's Generic PhosLo GelCaps
By Megan Leonhardt · January 17, 2012, 2:44 PM EST
Fresenius Medical Care Holdings Inc. on Friday lodged a patent infringement suit in Massachusetts federal court in an effort to block Nostrum Laboratories Inc. from marketing a generic version of kidney...
To view the full article, register now.